Connect Biopharma Holdings Limited
3580 Carmel Mountain Road, Suite 200
San Diego, CA 92130
June 24, 2025
VIA EDGAR
Alan Campbell
Office of Life Sciences
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Connect Biopharma Holdings Limited |
Registration Statement on Form F-3
File No. 333-287918
To the addressee set forth above:
Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Connect Biopharma Holdings Limited, respectfully requests that the effective date of the Registration Statement on Form F-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on June 26, 2025, or as soon as practicable thereafter.
If you have any questions or require additional information, please contact Michael E. Sullivan of Latham & Watkins LLP at (858) 523-3959. Thank you for your assistance and cooperation in this matter.
| Sincerely, | ||
| CONNECT BIOPHARMA HOLDINGS LIMITED | ||
| By: |
/s/ Jeff Cohn | |
| Jeff Cohn | ||
| General Counsel and Corporate Secretary | ||
| cc: | Barry Quart, Pharm.D., Connect Biopharma Holdings Limited |
Michael E. Sullivan, Latham & Watkins LLP